Floatz logo

Calcium folinate pentahydrate

Gastrointestinal Neoplasms

Janssen Research & Development, LLCSmall moleculePhase 3Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
81/ 100

Competitive context

16 Active assets in the Gastrointestinal Neoplasms cohort.

Asset / SponsorPhaseRating
Capecitabine
China Medical University, China
Phase 3BB
Eloxatin
Janssen Research & Development, LLC
Phase 3BB
Irinotecan
Pfizer
Phase 3BB
FLUOROURACILUM
Janssen Research & Development, LLC
Phase 3BB
(+)-VINCRISTINE
Pfizer
Phase 3B

View all 34 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →